ZBH · News · 20260805N

Market Demand Trends

ZIMMER BIOMET HOLDINGS, INC. · 2026-08-05 · Importance 31 · Surprise 32

Zimmer Biomet reported 4.0% organic constant-currency sales growth in the second quarter, with implant demand described as strong. Hip sales were a primary growth driver, particularly in the United States, while knee performance remained weaker. Management cited a healthy orthopedic market and expected weighted-average market growth of 5% to 6% by 2030.

Key facts

• Zimmer Biomet stock rose about 4.27% in pre-market trading after Q2 beats and guidance raise source
• Zimmer Biomet's stock rose 2.45% to $98.16 on Wednesday and was 9.35% below its 52-week high at close source